Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2018

  • ID: 4577082
  • Report
  • 77 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Aporo Biomedical, Inc.
  • CardioDex Ltd
  • Cook Medical Inc
  • Essential Medical Inc
  • Mayo Clinic
  • Rex Medical LP
  • MORE
Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2018

Summary

The author's Medical Devices sector report, “Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2018" provides an overview of Arteriotomy Closure Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Arteriotomy Closure Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by the author's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Arteriotomy Closure Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Arteriotomy Closure Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Arteriotomy Closure Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Aporo Biomedical, Inc.
  • CardioDex Ltd
  • Cook Medical Inc
  • Essential Medical Inc
  • Mayo Clinic
  • Rex Medical LP
  • MORE
1 Table of Contents

2 Introduction
2.1 Arteriotomy Closure Devices Overview

3 Products under Development
3.1 Arteriotomy Closure Devices - Pipeline Products by Stage of Development
3.2 Arteriotomy Closure Devices - Pipeline Products by Segment
3.3 Arteriotomy Closure Devices - Pipeline Products by Territory
3.4 Arteriotomy Closure Devices - Pipeline Products by Regulatory Path
3.5 Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date
3.6 Arteriotomy Closure Devices - Ongoing Clinical Trials

4 Arteriotomy Closure Devices - Pipeline Products under Development by Companies
4.1 Arteriotomy Closure Devices Companies - Pipeline Products by Stage of Development
4.2 Arteriotomy Closure Devices - Pipeline Products by Stage of Development

5 Arteriotomy Closure Devices Companies and Product Overview
5.1 Aporo Biomedical, Inc. (Inactive) Company Overview
5.1.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.2 Boston Scientific Corp Company Overview
5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.3 CardioDex Ltd (Inactive) Company Overview
5.3.1 CardioDex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.4 CloSys Corp Company Overview
5.4.1 CloSys Corp Pipeline Products & Ongoing Clinical Trials Overview
5.5 Cook Medical Inc Company Overview
5.5.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 CPC of America Inc Company Overview
5.6.1 CPC of America Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Essential Medical Inc Company Overview
5.7.1 Essential Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Harvard University Company Overview
5.8.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview
5.9 Mayo Clinic Company Overview
5.9.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
5.10 ProMed, Inc. Company Overview
5.10.1 ProMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.11 Rex Medical LP Company Overview
5.11.1 Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview
5.12 Sheba Medical Center Company Overview
5.12.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.13 Terumo Interventional Systems Company Overview
5.13.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
5.14 University of Rochester Company Overview
5.14.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
5.15 Vascular Closure Systems Inc Company Overview
5.15.1 Vascular Closure Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Vivasure Medical Ltd. Company Overview
5.16.1 Vivasure Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview

6 Arteriotomy Closure Devices- Recent Developments
6.1 May 16, 2018: Boston Scientific Announces Schedule of Presentations at EuroPCR 2018
6.2 May 14, 2018: Vivasure Medical to exhibit at EuroPCR 2018
6.3 May 07, 2018: Cardiva Medical Announces Completion of the AMBULATE Pivotal Trial
6.4 May 04, 2018: Ross Harvey named new director of global Customer Support & Delivery at Cook Medical
6.5 May 03, 2018: Cardinal Health Announces Third-quarter Results for Fiscal Year 2018
6.6 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management
6.7 Apr 09, 2018: Houston Methodist The Woodlands Hospital is first hospital in The Woodlands to offer an alternative to long-term warfarin medication to reduce the risk of stroke
6.8 Apr 05, 2018: Cardiva Medical Announces FDA Approval of VASCADE Vascular Closure System for Use in Femoral Vein Closure
6.9 Mar 23, 2018: JenaValve Technology Appoints Keith D Dawkins MD as Board Member
6.10 Mar 15, 2018: Concord Hospital Offers WATCHMAN Device for Patients with Atrial fibrillation
6.11 Feb 08, 2018: Cardinal Health Reports Second-quarter Results for Fiscal Year 2018
6.12 Feb 07, 2018: Cardinal Health Adds Akhil Johri to its Board of Directors
6.13 Feb 02, 2018: JenaValve Technology Appoints Laura A Brenton as Vice President of Clinical and International Market Development
6.14 Jan 08, 2018: MANTA Large Bore Vascular Closure Device IDE Study Completes 60-day Patient Follow up, Clearing the Way to FDA Submission
6.15 Nov 06, 2017: Cardinal Health Reports First-quarter Results for Fiscal Year 2018
6.16 Nov 06, 2017: Cardinal Health Outlines Leadership Succession Plan
6.17 Nov 02, 2017: Five-year Follow-up Data Demonstrate the WATCHMAN Left Atrial Appendage Closure Device Provides Stroke Risk Reduction Comparable to Warfarin Therapy
6.18 Oct 23, 2017: Boston Scientific Presents Clinical Trial Data of WATCHMAN Device at Transcatheter Cardiovascular Therapeutics 2017
6.19 Oct 13, 2017: Vivasure Enrolls First Patient in Frontier IV Clinical Trial
6.20 Oct 09, 2017: The MANTA Large Bore Vascular Closure Device to be Evaluated in a 500-patient European Post Market Clinical Registry
6.21 Oct 02, 2017: Essential Medical Completes Enrollment in US IDE Trial for the MANTA Large Bore Vascular Closure Device Used Primarily in Percutaneous Heart Valve Replacement Procedures
6.22 Sep 19, 2017: Vivasure Medical to present their PerQseal technology at PCR London Valves 2017
6.23 Sep 12, 2017: Vasorum Launches Celt ACD Second Generation Vascular Closure Device in the USA
6.24 Aug 08, 2017: Essential Medical Marks First 1,000 MANTA Cases and Expands Production Capacity
6.25 Aug 02, 2017: Cardinal Health Reports Q4 and Fiscal 2017 Results, Provides 2018 Guidance

7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Arteriotomy Closure Devices - Pipeline Products by Stage of Development
Table 2: Arteriotomy Closure Devices - Pipeline Products by Segment
Table 3: Arteriotomy Closure Devices - Pipeline Products by Territory
Table 4: Arteriotomy Closure Devices - Pipeline Products by Regulatory Path
Table 5: Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date
Table 6: Arteriotomy Closure Devices - Ongoing Clinical Trials
Table 7: Arteriotomy Closure Devices Companies - Pipeline Products by Stage of Development
Table 8: Arteriotomy Closure Devices - Pipeline Products by Stage of Development
Table 9: Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Femoral Artery Closure Device - Product Status
Table 11: Femoral Artery Closure Device - Product Description
Table 12: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 13: WATCHMAN Device - Oral Anticoagulation - Product Status
Table 14: WATCHMAN Device - Oral Anticoagulation - Product Description
Table 15: WATCHMAN FLX - Product Status
Table 16: WATCHMAN FLX - Product Description
Table 17: WATCHMAN Left Atrial Appendage System - Product Status
Table 18: WATCHMAN Left Atrial Appendage System - Product Description
Table 19: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 20: WATCHMAN Left Atrial Appendage System - A Prospective, Multi-center, Pilot Study to Compare the Safety and Effectiveness of WATCHMAN Left Atrial Appendage Occlusion Device with Rivaroxaban for Stroke Prevention in Patients with Atrial Fibrillation
Table 21: WATCHMAN Left Atrial Appendage System - AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial
Table 22: WATCHMAN Left Atrial Appendage System - China Registry of WATCHMAN Left Atrial Appendage Closure for Non-valvular Atrial Fibrillation
Table 23: WATCHMAN Left Atrial Appendage System - Comparison of Amplatzer Amulet vs. Watchman Device in Patients Undergoing Left Atrial Appendage Closure: the SWISS-APERO Randomized Clinical Trial
Table 24: WATCHMAN Left Atrial Appendage System - Comparison of Safety and Efficacy of Left Atrial Appendage Occlusion Devices
Table 25: WATCHMAN Left Atrial Appendage System - Continued Access To PREVAIL (CAP2)- Watchman Left Atrial Appendage (LAA) Closure Technology
Table 26: WATCHMAN Left Atrial Appendage System - Interventional Left Atrial Appendage Closure Vs. Novel Anticoagulation Agents in High-risk Patients with Atrial Fibrillation (PRAGUE-17 Study)
Table 27: WATCHMAN Left Atrial Appendage System - Left Atrial Appendage Closure Compared to Standard Antiplatelet Therapy in Patients with AF Who Underwent Percutaneous Coronary Intervention
Table 28: WATCHMAN Left Atrial Appendage System - Long Term Clinical Outcomes of Left Atrial Appendage Occlusion Versus New Oral Anticoagulants for Stroke Prevention in Patients with Non-valvular Atrial Fibrillation: From Korean Multicenter Registry
Table 29: WATCHMAN Left Atrial Appendage System - Protection Against Embolism for Non-valvular AF Subjects: Investigational Device Evaluation of the Watchman FLX LAA Closure Technology
Table 30: WATCHMAN Left Atrial Appendage System - Registry of Left Atrial Appendage Occlusion with WATCHMAN Device in Patients with Non-valvular Atrial Fibrillation and End-stage Chronic Kidney Disease on Hemodialysis
Table 31: WATCHMAN Left Atrial Appendage System - Registry on WATCHMAN Outcomes in Real-life Utilization
Table 32: WATCHMAN Left Atrial Appendage System - Registry on WATCHMAN Outcomes in Real-Life Utilization WASP Registry
Table 33: WATCHMAN Left Atrial Appendage System - The Evaluation of Thrombogenicity in Patients Undergoing WATCHMAN Left Atrial Appendage Closure Trial
Table 34: WATCHMAN Left Atrial Appendage System - The WASPS Trails:WATCHMAN for Second Prevention of Stroke
Table 35: WATCHMAN Left Atrial Appendage System - Watch Bleeding Episodes after Left Atrial Appendage Occlusion Versus Usual Care in Patients with Atrial Fibrillation and Severe to end-stage Chronic Kidney Disease (WatchAFIB in CKD)
Table 36: WATCHMAN Left Atrial Appendage System - Watchman FLX Left Atrial Appendage Closure Device Post Approval Study
Table 37: WATCHMAN Left Atrial Appendage System - WATCHMAN for Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement
Table 38: WATCHMAN Left Atrial Appendage System - WaveCrest Versus Watchman Transseptal LAA Closure to Reduce AF-Mediated Stroke 2. A Prospective, Multicenter, Randomized, Active Controlled, Clinical Trial of the Coherex WaveCrest Left Atrial Appendage Occlusion System Compared to the Watchman LAA Closure Device for the Reduction in Risk of Ischemic Stroke or Systemic Embolism in Subjects with Non-valvular Atrial Fibrillation That Have an Appropriate Rationale to Seek a Non-pharmacologic Alternative to Chronic Oral Anticoagulation
Table 39: WATCHMAN Device - Oral Anticoagulation - Assessment of the Watchman Device in Patients Unsuitable for Oral Anticoagulation: ASAP-TOO
Table 40: CardioDex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 41: EpiClose Plus - Product Status
Table 42: EpiClose Plus - Product Description
Table 43: CloSys Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 44: CloSys HD - Product Status
Table 45: CloSys HD - Product Description
Table 46: Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: X-Port Vascular Access Closure Device - Product Status
Table 48: X-Port Vascular Access Closure Device - Product Description
Table 49: CPC of America Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: MedClose - Product Status
Table 51: MedClose - Product Description
Table 52: Essential Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 53: MANTA - Product Status
Table 54: MANTA - Product Description
Table 55: X-Seal - Product Status
Table 56: X-Seal - Product Description
Table 57: Essential Medical Inc - Ongoing Clinical Trials Overview
Table 58: X-Seal - US Clinical Trial for the X-Seal 6F Vascular Closure Device
Table 59: MANTA - Post-market Clinical Registry to Evaluate the Safety and Performance of MANTA Vascular Closure Device (VCD) Under Real World Conditions in the European Union (EU)
Table 60: MANTA - Safety and Efficacy of Large Bore Vascular Closure Device: A prospective, Multi-center, European Post Market Clinical Study
Table 61: Harvard University Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Access-Closure Device - Product Status
Table 63: Access-Closure Device - Product Description
Table 64: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Left Atrial Appendage Closure Device - Product Status
Table 66: Left Atrial Appendage Closure Device - Product Description
Table 67: ProMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Large Hole Closure Device - Product Status
Table 69: Large Hole Closure Device - Product Description
Table 70: Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Auto-Close Vascular Sealing System - Product Status
Table 72: Auto-Close Vascular Sealing System - Product Description
Table 73: Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table 74: Left Atrial Appendage Intraatrial Transcatheter Sutureless Closure - Product Status
Table 75: Left Atrial Appendage Intraatrial Transcatheter Sutureless Closure - Product Description
Table 76: Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
Table 77: Vascular Closure Device - Product Status
Table 78: Vascular Closure Device - Product Description
Table 79: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
Table 80: Vascular Closure Device - Product Status
Table 81: Vascular Closure Device - Product Description
Table 82: Vascular Closure Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 83: FastSeal Bioabsorbable Vascular Access Closure System - Product Status
Table 84: FastSeal Bioabsorbable Vascular Access Closure System - Product Description
Table 85: FastSeal Bioabsorbable Vascular Access Closure System - 18 Fr - Product Status
Table 86: FastSeal Bioabsorbable Vascular Access Closure System - 18 Fr - Product Description
Table 87: FastSeal Self - Closing Nitinol Clip System - Product Status
Table 88: FastSeal Self - Closing Nitinol Clip System - Product Description
Table 89: FastSeal Swellable And Bioabsorbable Tubular Plug System - Product Status
Table 90: FastSeal Swellable And Bioabsorbable Tubular Plug System - Product Description
Table 91: Vivasure Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 92: PerQseal - Product Status
Table 93: PerQseal - Product Description
Table 94: Vivasure Medical Ltd. - Ongoing Clinical Trials Overview
Table 95: PerQseal - Expanded Indication Study of Proprietary PerQseal Large Arteriotomy Closure Technology: Frontier IV Clinical Study
Table 96: Glossary

List of Figures
Figure 1: Arteriotomy Closure Devices - Pipeline Products by Stage of Development
Figure 2: Arteriotomy Closure Devices - Pipeline Products by Segment
Figure 3: Arteriotomy Closure Devices - Pipeline Products by Territory
Figure 4: Arteriotomy Closure Devices - Pipeline Products by Regulatory Path
Figure 5: Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date
Figure 6: Arteriotomy Closure Devices - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Aporo Biomedical, Inc.
  • Boston Scientific Corp
  • CardioDex Ltd
  • CloSys Corp
  • Cook Medical Inc
  • CPC of America Inc
  • Essential Medical Inc
  • Harvard University
  • Mayo Clinic
  • ProMed, Inc.
  • Rex Medical LP
  • Sheba Medical Center
  • Terumo Interventional Systems
  • University of Rochester
  • Vascular Closure Systems Inc
  • Vivasure Medical Ltd.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll